Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 72% CR at any point in time.

<< Previous

Bullboard Posts

Next >>

Comment by wildbird1on Apr 30, 2023 7:44pm

198 Views

Post# 35422046

RE:RE:RE:RE:RE:72% CR at any point in time.

In the Nov,2022 Assesment chart there is 29 evaluable patients at 450 days.
In the Nov,2022 Swimmer Plot there is 11 patients at 450 days.

In the April 2023 Assesment chart there is 12 evaluable patients at 450 days.
In the April 2023 Swimmer Plot there is 12 patients at 450 days.

The only difference seem to be that the 2023 Assesment chart and the Swimmer Plot are synchronised.

That make the numbers easier to follow.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?